Is it time to buy into Chinese stocks?
SHANGHAI, Jan 20 (Reuters) – China lowered mortgage lending benchmark rates on Thursday as monetary authorities step up efforts to prop up the slowing economy, after data earlier in the week pointed to a darkening outlook for the country’s troubled property sector. Continue reading →

Yesterday I mentioned that the price of Gold was moving above resistance lines and was or about to break out of a range-bound chart pattern. Continue reading →

Emerging Market ETFs are in lower risk chart patterns but are lacking a strong catalyst for driving their price higher.
Catalysts likely are, a falling US Dollar, rising commodity prices, and asset rotation out of US equities and debt.
VWO appears to be the better positioned of the emerging Market ETFs in relationship to its moving averages. Continue reading →

Companies to consider buying
Six to Thirty-six months, for the double. That beats bank returns. Ideas to accumulate on the dip.

• Admittedly, these suggestions are focused on Company Strength, Value and Time duration. A consistent dollar-cost-averaging and tax management strategy would be employed to manage risk. The goal is grow position size and build wealth.
• This is probably not appealing if you like short-term trading and adrenaline. Battle Focused.
• Miners listed below are the exception to the long duration pitch. Gold is hot now, silver will follow.
• If you enjoy a thinking game – strategy combined with tactical positioning with size for wealth building and Winning The War, this is an exciting time to be buying.

Continue reading →

LOTM readers are well aware, we work with the attitude to Buy Companies and Trade Stocks.

When making a purchase – we determine which of the two categories mentioned above the purchase will fall into. Continue reading →

Re: Soluna Holdings (SLNH)* $8.40

John Belizaire is the CEO of Soluna Computing.
Soluna Computing is the world’s first utility-scale company combining Alternative Power Generation with high-performance computing facilities. Continue reading →

Unloved and over-sold, XBI the S&P Biotech ETF, is attractive for a short-term over-sold bounce and a long-term accumulation perspective. Continue reading →

LOTM: Ten Under $10 comment Jan 29, 2022
GATOS Silver: Lots of price drama this week. The share price dropped from about $10 to Fridays close of $3.06. We are impressed by the drop mainly because we not that impressed by the news. Yes, it was a shock. And yes, we are uncertain of the ultimate outcome. The company stated that reserves were overstated – possibly by 50%. The adjustment will not be known for six to eight months. In addition to the reserve downgrade, a number of brokers downgraded the shares from out-perform to under-perform. The fall in price triggered margin selling. At $3.00 all margin related to the shares has to be 100% paid off. That tough situation and acts like a magnet drawing the share price to the $3.00 area where the stock needs to be fully paid for. Continue reading →